Mapping chromatin remodelling in glioblastoma identifies epigenetic regulation of key molecular pathways and novel druggable targets
Abstract Background Glioblastoma is the most common and aggressive malignant brain tumour in the adult population and its prognosis is dismal. The heterogeneous nature of the tumour, to which epigenetic dysregulation significantly contributes, is among the main therapeutic challenges of the disease....
Saved in:
Main Authors: | Claire Vinel, James Boot, Weiwei Jin, Nicola Pomella, Alexandra Hadaway, Charles Mein, Nicolae Radu Zabet, Silvia Marino |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2025-02-01
|
Series: | BMC Biology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12915-025-02127-9 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Sex differences in epigenetic ageing for older people living with HIVResearch in context
by: Carrie D. Johnston, et al.
Published: (2025-03-01) -
Editorial: Genetics and epigenetics in ovarian aging
by: Honey V. Reddi
Published: (2025-02-01) -
Neurocognitive function and health-related quality of life among glioblastoma patients: A prospective study
by: Mohamed A Baba, et al.
Published: (2025-01-01) -
Chromatin remodeling (SWI/SNF) complexes, cancer, and response to immunotherapy
by: Razelle Kurzrock, et al.
Published: (2022-09-01) -
Escherichia coli combination with PD-1 blockade synergistically enhances immunotherapy in glioblastoma multiforme by regulating the immune cells
by: Guochen Li, et al.
Published: (2025-02-01)